Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Exosomes from umbilical cord cells fix hearing loss and damaged ear hair cells in mice.

Umbilical cord-derived media is safe and effective for hair growth.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Ayurvedic treatment helped improve PCOD symptoms and ultrasound results.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.